Article
Ethosuximide reduces epileptogenesis and behavioral comorbidity in the <scp>GAERS</scp> model of genetic generalized epilepsy
6 Mar 2013
Abstract excerpt
PURPOSE: Ethosuximide (ESX) is a drug of choice for the symptomatic treatment of absence seizures. Chronic treatment with ESX has been reported to have disease-modifying antiepileptogenic activity in the WAG/Rij rat model of genetic generalized epilepsy (GGE) with absence seizures. Here we examined whether chronic treatment with ESX (1) possesses antiepileptogenic effects in the genetic absence epilepsy rats from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
